Biologically, PRDM16 overexpression in AML cells may promote leukemic cells to survive under stress conditions of the bone marrow microenvironment, contributing to their resistance to differentiation, cell death and treatment [5, 9]. Here, PRDM16 is linked to acute myeloid leukemia.